Glaxosmithkline Share News (GSK)

IN BRIEF: WuXi Biologics signs exclusive deal with GSK

WuXi Biologics Inc - China-based contract research, development & manufacturing organisation, offering end-to-end biologics solutions - Enters into a license deal with GSK PLC for one preclinical bi-specific T cell engaging antibody and the option of three additional bi- & multi-specific TCE antibodies developed using WuXi Biologics' proprietary technology platforms. Says WuXi Biologics will get an upfront payment of USD40 million and tiered royalties on net sales.

LONDON BRIEFING: Next, Greggs and B&M saw festive cheer

(Alliance News) - Stocks in London are set to open lower on Thursday in the wake of Federal Open Market Committee meeting minutes released on Wednesday.

Sanofi sees decision on Zantac dispute with Boehringer in Q1 at earliest

Arbitration decision initially expected by end of 2022

*

LONDON BROKER RATINGS: Citigroup cuts Wizz Air; Redburn likes CRH

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning, Monday and late Friday:

LONDON MARKET OPEN: Stocks jump in first session of 2023

(Alliance News) - Stock prices in London made a strong start to the new year on Tuesday, despite weak Chinese data and the UK suffering a fresh wave of rail strikes.

LONDON BRIEFING: Stocks called higher; China factory sector shrinks

(Alliance News) - Stocks in London are expected to start a new year on the front foot on Tuesday, after a mixed session in Asia amid weak Chinese economic data.

GSK plans return of HQ to central London in 2024

(Sharecast News) - GSK on Monday said it was moving its global headquarters back to central London in 2024.

Unilever mulls $3 bln sale of some U.S. ice cream brands - Bloomberg News

Dec 8 (Reuters) - British consumer goods giant Unilever is considering the sale of a portfolio of U.S. ice cream brands such as Klondike and Breyers, that could be valued at as much as $3 billion, Bloomberg News reported on Thursday.

LONDON BROKER RATINGS: JPMorgan cuts Travis Perkins; BofA likes IAG

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

FTSE 100 hits 1-week low amid broader gloom, GSK surges

GSK escapes U.S. lawsuit on Zantac allegations

*

European shares fall for fourth day on growth worries

STOXX 600 falls for the fourth straight day

*

LONDON MARKET CLOSE: Pharma stocks fail to lift FTSE 100 in the green

(Alliance News) - Stocks in London closed in the red on Wednesday, despite a strong performance from pharmaceutical stocks, as investors digested a raft of economic data from both China and Europe.

GSK, Sanofi shares soar as Zantac litigation fears abate

Thousands of Zantac lawsuits dismissed on Tuesday

*

LONDON MARKET MIDDAY: Stocks slide amid risk-off mood after China data

(Alliance News) - Stocks in Europe were mostly in the red on Wednesday, as economic data from China stoked fear of a global slowdown, while the FTSE 100 was spared a steeper decline thanks to gains by pharmaceutical stocks.

Winter is coming... and so are earnings downgrades

STOXX 600 falls 0.5%

*